By Madeline Lyskawa ( October 22, 2021, 7:35 PM EDT) -- Taiwanese pharmaceutical company PharmaEssentia renewed its bid to toss litigation over a disputed €142 million ($165 million) arbitral award secured by Austrian pharmaceutical company AOP Orphan, saying a Massachusetts federal court lacks jurisdiction over the suit because the company has insufficient ties to the state....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.